New potential indications for GLP-1 agonist should be also investigated, such as insulin resistance, prediabetes and sarcopenia
In the context of GLP-1RAs, metabolic reprogramming involves modulating energy metabolism and regulating cardiac function and pathological remodeling through various mechanisms (12, 13)
Our free 3-minute DiabeSCORE quiz analyses your symptoms, lifestyle, and risk factors to give you a personalised metabolic health score and tells you exactly where your GLP-1 system may need support
Lipodystrophy: the main risk of poor rotation Injecting repeatedly into the same spot causes a condition called lipodystrophy
Ensure only minimal air bubbles remain in the syringe
References Pillinger T, McCutcheon RA, Vano L, et al